Sudden reductions in effective intravascular volume during hemodialysis are a consequence of ultrafiltration and of intracellular fluid shifts due to the urea gradient which develops between intravascular and intracellular compartments (1) . The magnitude of this decrease in intravascular volume is also determined by the rate at which refilling from the interstitial compartment occurs (2) . These volume shifts are undoubtedly a major cause of hypotension in some patients. In others, however, blood pressure is maintained despite a reduced intravascular volume.
Factors related to the hemodialysis procedure as well as certain physiologic abnormalities may cause hypotension by decreasing peripheral resistance or depressing myocardial function (Fig. 1) . While the physiologic abnormalities are difficult to treat, the recognition and modification of dialytic factors has improved hemodynamic stability in some patients. The use of high sodium dialysate minimizes intracellular volume shifts by lessening the transcellular osmolar gradient (3). Hemofiltration (4) and the use of cooled dialysate (5) prevent the vasodilation caused by the warming effect of standard (37°) dialysis. The use of reprocessed dialyzers, cellulose acetate or polyacrylonitrile based dialyzers results in less complement (6) and neutrophil activation (7) than cuprophane dialyzers and decreases the incidence of hypersensitivity reactions (8) . The vasodilatory and negative inotropic effects of acetate are avoided in acetate sensitive individuals by using bicarbonate dialysate (9) . The use of high calcium dialysate increases total systemic resistance and has a positive inotropic effect (10) . The reasons why some patients are more prone than others to the hypotensive effects of these dialytic factors is only just beginning to be understood (11, 12) .
Reports on physiologic abnormalities in dialysis patients often conflict, and few studies have related diThe International Journal Of Artificial Organs I Vol. 11 I no. 5, 1988 I pp. 325-328 rectly these abnormalities to the hemodynamic instability. Still, an understanding of the mechanisms which normally protect against hypotension during hypovolemia and their alterations in uremia provides an approach for future investigations and individual patient management. Figure 1 schematically illustrates the interactions of the sympathetic nervous system, the renin-angiotensin axis, and vasopressin containing neurons in the normal response to volume depletion or hypotension.
Major disruption of the sympathetic nervous system response could cause hemodialysis instability. This may result from baroreceptor (afferent) dysfunction or from defective release of catecholamines by sympathetic (efferent) nerve endings. Afferent dysfunction might also impair vasopressin release. The extent and significance of sympathetic dysfunction in dialysis patients (13, 14) is widely debated. This confusion arises largely from oversimplified interpretation of the common tests of autonomic function.
It has commonly been assumed that an abnormal Valsalva maneuver (which tests the whole sympathetic reflex arc) coupled with a normal cold pressor test (said to test only efferent sympathetic activity) is proof of an afferent sympathetic defect. This combination has been widely reported in dialysis patients (15) . In reality, it is only the bradycardic response to Valsalva release that is commonly impaired. The overshoot blood pressure (16) and the tachycardia during the strain phase are intact (17) . Figure 2 demonstrates that this "autonomic neuropathy" is consistent with an isolated parasympathetic defect, not a baroreceptor abnormality. The same misconception is responsible for other reports of "baroreceptor insensitivity" based on diminished slowing of the pulse rate during phenylephrine effusion (18) . High concentrations of endogenous opioids may partially account for this parasympathetic dysfunction (17) .
It is easy to understand, then, why "autonomic neuropathy" and "baroreceptor dysfunction" are commonly reported even though plasma norepinephrine concentrations are high during epidoses of dialytic hypotension (19) . That plasma norepinephrine concentrations rise during dialysis in both stable and hypotension prone patients (20) is in agreement with the notion that sympathetic insufficiency is not a common cause of instability during hemodialysis. Catecholamine depletion due to losses into the dialysate fluid, although hypothesized, is unlikely to be significant in view of stable or rising plasma catecholamine concentrations found during hemodialysis (19) . In contrast, the peripheral vascular response to norepinephrine is diminished in dialysis patients, especially in hypotension prone individuals (21) . High ci rculating levels of parathyroid hormone (22) , decreased numbers of adrenergic receptors (23) , and post receptor insensitivity (24) to catecholamines have been implicated as having pathogenetic importance.
Much less is known about arginine vasopressin (AVP) release during dialysis. Baseline plasma AVP concentrations are normal or high in dialysis patients but do not increase during exercise (25) ultrafiltration (26) . In hypotension prone dialysis patients plasma AVP concentrations fail to rise even during severe hypotensive episodes, but may increase markedly with vomiting (27) . Although confirmatory studies are necessary, inadequate AVP release may predispose to hypotension in some dialysis patients. Potential therapeutic implications are suggested by reports of a favorable response to intranasal lysine vasopressin in some patients with refractory hypotension (28) .
The normal release of and peripheral response to angiotensin may also be important in maintaining blood pressure during hemodialysis. Plasma concentrations of angiotensin II in dialysis patients rise on standing but do not increase normally with exercise (25) . Decreases in plasma volume during hemodialysis cause plasma renin activity and aldosterone to increase in most non-nephrectomized patients (19) . While the renin-angiotensin axis itself appears to be intact, vascular sensitivity to infused angiotensin II is significantly decreased (21, 25) . The decrease in angiotensin II receptors which has been recently reported in dialysis patients (29) is a potential cause of decreased vascular sensitivity.
Thus a variety of factors may cause hypotension during hemodialysis. Some of these factors are well recognized and may be manipulated to minimize their hypotensive effects. Since our knowledge of physiological abnormalities disrupting the normal autonomic response to volume depletion in dialysis patients is not firmly established, therapeutic approaches in this area are still suboptimal. The sympathetic nervous system and the renin-angiotensin axis are normal in most patients, but peripheral resistance to the vasoconstrictive effects of norepinephrine and angiotensin II may be important in the etiology of hemodialysis
